Robert is a successful venture capitalist and Silicon Valley tech operator, and an all-around great guy. Robert joined NVP (Norwest Venture Partners) in 1998 and is focused on a wide variety of investment categories, including mobile, cloud & IT infrastructure. His current investments and board seats include Act-On Software, ClariPhy, ClearDATA, Elemental, mBlox, Mozes and Zenverge. Robert was formerly a member of the board of directors of Brand.net (acquired by Valassis Communications), Covigo (acquired by Symbol Technologies), KACE (acquired by Dell), Occam Networks (acquired by Calix), Resonext Communications (acquired by RF Micro Devices) and SideStep (acquired by Kayak). He has also worked with such companies as Embark (acquired by Princeton Review), Escalate (acquired by GERS), Kayak (Nasdaq: KYAK), mPower (acquired by Morningstar) and Quantum Effect Devices (acquired by PMC-Sierra).

Robert has nine years of operational experience in various roles, from engineering to marketing and product management. Before joining NVP, he was at Silicon Graphics. Prior to Silicon Graphics, Robert worked at IBM-ROLM Systems.

He holds a Bachelor of Science and a Master of Science in electrical engineering and an MBA, all from Stanford University.

Vin is a partner at HLM Venture Partners and leads the firm’s healthcare technology accelerator and start-up efforts. Vin holds several portfolio company board seats and observer roles, oversees investor relations and communications, administrative functions, and is active in various aspects of new investment due diligence. Vin is a board member of HLM portfolio companies ClearDATA and Prism Education and is an observer at ArroHealth, Binary Fountain and Persivia.  Vin is also on the board of Zillion. Vin has been a mentor to various start-up companies through several healthcare accelerator programs, including, among others AidIn, Credsimple, Luminate Health, WellTrackOne and MediQuire. Prior to joining HLM, Vin held several senior financial executive positions in the financial services industry, including Vice President-General Manager at First Data Investors Services where he was responsible for managing a $35M division providing outsourced accounting and administrative services to mutual fund and brokerage companies and developing offshore administration and global custody businesses to support clients’ international growth. Vin is a former Director of the Private Equity CFO Association as well as several nonprofit board roles.

Bill is a General Partner at Flare Capital Partners. Prior to co-founding Flare Capital Partners, Bill was with North Bridge Venture Partners since its inception in 1994.

During Bill’s more than 20-year tenure investing in young and emerging healthcare technology companies, he has served on the Boards of numerous industry-leading companies and played a critical role, actively helping and working closely with founders and management. Flare Capital Partners is focused exclusively on healthcare technology and investments include Aetion, Bright Health, Circulation, ClearDATA, Curisium, Health Verity, HealthReveal, Iora Health, Valence Health (Evolent Health), VisitPay and Welltok. In Bill’s prior firm, healthcare technology investments included Humedica (Optum Analytics), Connance, Phase Forward (Oracle), Pharmetrics (IMS Health), NaviNet (Nant Health) and eBenX (ADP).

Previously, Bill was a Partner at Hambro International Equity Partners. Prior to that, he was Chief Financial Officer at MathSoft, a science and engineering applications software start-up that went public on the NASDAQ and was later acquired by a leading design and product lifecycle software solutions company, and a CPA at Arthur Andersen and Company.

Bill received an undergraduate degree from Boston College’s Carrol School of Management Honors Program and has served his alma mater in a variety of capacities, including former Chair of the Board of Trustees and current member of its Investment and Endowment Committee. He has been Chair of the Parents Committee of Duke University and Chair of the Stanford University Parents Advisory Board. Additionally, Bill is on the Board of the MGH Institute of Health Professions, was appointed by the Massachusetts Governor, Charlie Baker, to the Oversight Council of the Center For Health Information and Analysis, and is on the Advisory Council of the Department of Biomedical Informatics at Harvard Medical School.  Reach Bill at bill@flarecapital.com.

Graham Hunter joined Heritage Group in 2012 and serves as a Partner for the firm. Prior to joining Heritage Group, Graham was an Associate with Ridgemont Equity Partners, a $3 billion private equity firm in Charlotte, NC focused on buyout and growth investments across a broad range of industries. While at Ridgemont, he played an active role in all aspects of deal execution and provided post-acquisition support to portfolio companies. From 2006-2009, he worked as an Analyst in Leveraged Finance at Bank of America Merrill Lynch. In that role, he helped originate, structure and execute approximately $30 billion in credit facilities to support leveraged buyouts, acquisitions, recapitalizations and refinancings.

Graham graduated cum laude with a B.A. in Economics from Davidson College. He resides in Nashville with his wife and two daughters.

Reed is the former President and CEO of ThreatMetrix, the leader in digital identities to provide identity authentication and fraud prevention. At ThreatMetrix, Reed guided the company from first product introduction to an $830M acquisition in 2018 by LexisNexis. Prior to joining ThreatMetrix, Reed was the president and CEO of Callidus Software, where he led the company from its inception through IPO. Reed has more than 30 years of experience scaling growth companies. He currently sits on the Board of Directors for Arkose Labs.

Caleb has nearly 20 years of operating, start-up and financing experience in life science and healthcare companies. He plays an instrumental role in sourcing and structuring deals and works closely with portfolio companies to form strategic partnerships and to develop commercialization and marketing strategies. He currently (or formerly) represents Excel as a Board Director or Observer at Aileron, Aventura, ClearData, InfoBionic, Molecular Templates, ShapeUp, Saladax, Biomedical and MedVentive (sold to McKesson).

Prior to joining Excel, Caleb was a Principal at Biotechonomy, where he financed and managed several entrepreneurial ventures, including Synthetic Genomics, where he was also the Director of Finance, BioTrove (sold to Life Technologies), Biocius (sold to Agilent Technologies), and Xcellerex (sold to GE).

Prior to becoming a venture capitalist, Caleb was an award-winning sales and marketing executive at medical device and diagnostics companies. He received his MBA from Babson College, magna cum laude, where he was a Babson Fellow in the Center for Technology Enterprise. He received a BA in Biology with a minor in Economics from Colby College.

Joe has more than two decades of experience in healthcare investing applying a technical engineering background coupled with an understanding of emerging technologies. He is considered to be one of the industry’s leading corporate investors. In 2016, Joe was named by Global Corporate Venturing as one of the top five rising stars.

Joe currently holds board seats with Aerosafe, ClearDATA, TriNetX, Prognos, Preventice and Volansi (observer). Previously he sat on the board of Koneksa, and has exited companies: Aptus Health, Exostar, Humedica, Liaison and Remedy Informatics. Joe chairs several M&A and audit committees at these companies while holding current board seats.

Joe has been instrumental in transforming Merck GHIF from a leader, not only in venture capital, but also in growth equity and M&A. He earned industry laurels when he participated in the sale of Humedica, a healthcare analytics company, to UnitedHealth Group in 2013, a transaction that produced a 17-fold return.

In addition to his success with Humedica, Joe has led investments and acquisitions in companies such as AeroSafe, TriNetX, Liaison, Preventice, Physicians Interactive, Koneksa, Prognos, Volansi, WellDoc, Exostar and ClearDATA. During this same period, he has also managed 60-plus transactions at Merck, all at various stages of maturity.

Joe is also renowned for his leadership with Preventice to further develop its remote care monitoring platform for cardiac arrhythmia patients. Joe led the Merck strategy and merger of Preventice with eCardio and eventually sold a portion of the combined company to a leading healthcare channel partner, which paid back the fund for the original investment while maintaining majority share of a more valued company. Joe also focused on the patient-physician engagement space with his Physicians Interactive (now called Aptus) investments. He eventually led the acquisition of the company on behalf of Merck GHIF. Joe also led the acquisitions of MedHelp, Quantia MD and Tomorrow Networks within Aptus.

Joe came to Merck from Johnson and Johnson where he spent more than 20 years in innovation and investment roles across Consumer, Pharma and Device sectors of J&J. Prior to that he was a consultant with EDS where he was selected and graduated from their Top Gun business and technology program. He went to the University of South Florida where he obtained a degree in Business/Information Systems and Engineering.

CISO and Head of IT Operations, Humana